Clinical Trial Update: DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating DEXTENZA for postoperative pain and inflammation after vitreoretinal surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreo-retinal Surgery

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Patrick R. Oellers, MD | Conditions: Vitreo-Retinal Surgery | Phase 4 | Status: COMPLETED